
US FDA issues guidance for development of cannabis-based medical drugs
27th January 2023 - News analysis |
The US Food and Drug Administration (FDA) has issued a final guidance document for the development of medical drugs containing cannabis
The US Food and Drug Administration (FDA) has issued a final guidance document for the development of medical drugs containing cannabis
The US Food and Drug Administration (FDA) has rejected a regulatory pathway that would allow CBD products to be treated as food additives or dietary supplements
Government and industry representatives from around the world met in Geneva last week to hear about the “significant economic opportunities” offered by industrial hemp and the need for greater clarity on its legal status
Licensed medical cannabis patients in the US state of Georgia can legally possess oils with less than 5% THC, but they can’t legally buy it due to legislative delays and a series of legal appeals
Belgium has set new rules for nicotine-free e-liquids, effectively banning all e-liquids containing CBD – and thereby setting up a possible conflict with EU law
This report provides a detailed overview of the current regulatory framework in place in Russia for hemp, CBD and cannabis, covering all areas of policy
Legislation to create a medical cannabis programme in the US state of Kansas appeared to be on the verge of success many times – but it died again as the 2022 session drew to a close
Cannabis consumption is a growing problem in Bavaria and its planned legalisation in Germany would further burden the country’s health system, Bavarian health minister Klaus Holetschek says
This report offers a comprehensive overview of the current regulatory framework in place in Denmark for hemp, CBD and other cannabinoids, as well as medical and recreational cannabis
The French Council of State has definitively ruled that a 2021 government decree banning hemp flowers is illegal and must be annulled. This major decision fully authorises French shops to sell CBD products, including flowers, without any fear of punishment for working outside the law
This report provides a detailed overview of Belgium’s federal and state regulation of hemp, CBD and cannabis, covering everything from cultivation to extracts and finished products, as well as the medical and recreational cannabis regimes
The US Food and Drug Administration (FDA) may soon issue recommendations for a long-awaited regulation of CBD products in the country
The German Ministry of Health’s budget has been slashed by €1m in a bid to put pressure on health minister Karl Lauterbach to present a draft law for the legalisation of cannabis
The recreational reputation of synthetic cannabinoids – synthetic cannabinoid receptor agonists (SCRAs) – precedes them, leading to restrictions on use and even research
This report provides an overview of the applicable framework for the movement of hemp and CBD within the borders of the EU as well as the import and export to and from “third countries”
Submit your access request to explore how it can streamlines access to critical cannabis insights
"*" indicates required fields